Metagenomi Therapeutics
Gene editing research and development
- B2B
About Metagenomi Therapeutics
Pioneers in CRISPR/CAS revolution, developing advanced gene-editing systems to treat genetic diseases and revolutionize the world through gene editing
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Emeryville, California, United States
- Revenue
- $25.2MFY2025, publicly reported
- Website
- metagenomi.co
- linkedin.com/company/metagenomi
Metagenomi Therapeutics at a glance
Metagenomi Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Emeryville, California, United States.
Metagenomi Therapeutics has 51–250 employees.
Metagenomi Therapeutics's revenue is $25.2M (FY2025, publicly reported).
Frequently asked questions about Metagenomi Therapeutics
What is Metagenomi Therapeutics's revenue?
Metagenomi Therapeutics's revenue is $25.2M (FY2025, publicly reported).
How many employees does Metagenomi Therapeutics have?
Metagenomi Therapeutics has 51–250 employees.
Where is Metagenomi Therapeutics headquartered?
Metagenomi Therapeutics is headquartered in Emeryville, California, United States.
Selling to companies like Metagenomi Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies